Results 141 to 150 of about 1,105,597 (253)

Surgical Removal of Residual Tumor Masses in Patients Undergoing Targeted Therapy for EGFR‐Mutated Locally Advanced or Metastatic Lung Cancer

open access: yesInternational Journal of Cancer, Volume 159, Issue 9, Page 2244-2261, 1 November 2026.
Non‐small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutations often exhibit significant tumor reduction following tyrosine kinase inhibitor (TKI) therapy. Residual tumors frequently remain, however, leading to drug resistance and disease progression.
Fedor Moiseenko   +31 more
wiley   +1 more source

Effects of 6‐OHDA‐Mediated Chemical Denervation of Sympathetic Axons in Inguinal Subcutaneous White Adipose Tissue

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 11, Page 10459-10474, November 2026.
ABSTRACT Aims White adipose tissue (WAT) innervation by sensory and sympathetic axons contributes to tissue functions, but the consequences of selectively disrupting sympathetic input to WAT remain incompletely defined. Materials and Methods We utilised 6‐hydroxydopamine (6‐OHDA) as a validated approach to achieve bilateral sympathetic denervation of ...
Gilian Gunsch   +15 more
wiley   +1 more source

The Relevance of Curative‐Intent Metastasectomy in Colorectal Cancer Patients: Real‐World Insights From a Certified Comprehensive Cancer Center in Germany

open access: yesInternational Journal of Cancer, Volume 159, Issue 8, Page 2025-2035, 15 October 2026.
Patients with metastatic colorectal cancer who are ineligible for upfront metastasectomy may still become candidates for secondary metastasectomy with curative intent following response to primary chemotherapy. However, most studies dichotomize metastatic colorectal cancer into resectable and unresectable disease.
Julian W. Holch   +18 more
wiley   +1 more source

Five‐Year Survival Analyses on Non‐Pathological Complete Response Esophageal Squamous Cell Carcinoma Patients After Neoadjuvant Regimens Plus Surgery: A Propensity Score Matching, Real‐World Cohort Study

open access: yesCancer Medicine, Volume 15, Issue 10, October 2026.
ABSTRACT Background Non‐pathological complete response (non‐pCR) is common in esophageal squamous cell carcinoma (ESCC) patients after neoadjuvant therapy, yet evidence guiding long‐term outcomes and postoperative risk stratification in the immunotherapy era remains limited.
Weibin Liu   +9 more
wiley   +1 more source

Head & Neck and Shoulder Desmoid‐Type Fibromatosis: Presentation and Natural History of These Ultra‐Rare Locations

open access: yesCancer Medicine, Volume 15, Issue 10, October 2026.
ABSTRACT Background Active surveillance is recommended as the first‐line management for desmoid‐type fibromatosis (DF); however, data on DF of the head and neck (H&N) and shoulder regions are limited. Methods We examined patients with DF located in the H&N and shoulder regions, comparing baseline characteristics and event‐free survival (EFS).
Nicolas Penel   +19 more
wiley   +1 more source

Preoperative Arterial Embolization Facilitating Safe Resection of a Hypervascular Aggressive Angiomyxoma: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 10, October 2026.
ABSTRACT A 22‐year‐old woman presented with a 12‐cm hypervascular aggressive angiomyxoma. Difficult hemostasis during biopsy prompted preoperative selective arterial embolization followed by complete macroscopic resection with only 50 mL of blood loss.
Yukako Takashima   +6 more
wiley   +1 more source

Optimising Clinical Outcomes Following R1 Resection in Soft Tissue Sarcoma: An Evidence-Based Approach. [PDF]

open access: yesCurr Treat Options Oncol
Remiszewski P   +6 more
europepmc   +1 more source

Pattern‐Based P53 Immunohistochemistry Predicts Recurrence in Colorectal Liver Metastases Without Complete Pathologic Response After Neoadjuvant Chemotherapy

open access: yesCancer Reports, Volume 9, Issue 10, October 2026.
ABSTRACT Background Aberrant p53 expression may have prognostic significance in colorectal cancer; however, its role in patients with colorectal liver metastases (CRLM) who receive neoadjuvant chemotherapy but do not achieve pathological complete response (pCR) remains unclear.
Phat Thi Hong Ho   +6 more
wiley   +1 more source

Redefining the R1 resection in patients with pancreatic ductal adenocarcinoma

open access: yesJournal of hepato-biliary-pancreatic sciences, 2016
P. Markov, S. Satoi, M. Kon
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy